Evaluation of Receptor Affinity, Analgesic Activity and Cytotoxicity of a Hybrid Peptide, AWL3020
Open Access
- 19 February 2020
- journal article
- research article
- Published by Springer Nature in International Journal of Peptide Research and Therapeutics
- Vol. 26 (4) , 2603-2617
Abstract
In the present contribution we report design, synthesis and evaluation of receptor affinity, analgesic activity and cytotoxicity of a hybrid peptide, AWL3020. The peptide includes two pharmacophores, one of δ-opioid receptor (δOR) agonists and one of neurokinin-1 receptor (NK1R) antagonists. The design was motivated by the desire to obtain a compound with strong analgesic action and potential additional antiproliferative action. The compound displays high δOR affinity (IC50 = 29.5 nM). On the other hand, it has only poor affinity for the NK1R (IC50 = 70.28 μM). The substance shows good analgesic action which is however weaker than that of morphine. Regarding the effect on proliferation, the compound exhibits no pro-proliferative action in the assayed range. In higher concentrations, it has also cytotoxic activity. This effect is however not selective. The strongest effect of AWL3020 was found for melanoma MeW164 cell line (EC50 = 46.27 μM in reduction of cell numbers after a few days of incubation; EC50 = 37.78 μM in MTT assay).Keywords
Funding Information
- European Social Fund, Human Capital Operational Programme (UDA-POKL.08.02.01-14-041/09)
This publication has 63 references indexed in Scilit:
- The Role of Neurokinin-1 Receptor in the Microenvironment of Inflammation and CancerThe Scientific World Journal, 2012
- Delta opioid receptor analgesiaBehavioural Pharmacology, 2011
- Design of Novel Neurokinin 1 Receptor Antagonists Based on Conformationally Constrained Aromatic Amino Acids and Discovery of a Potent Chimeric Opioid Agonist-Neurokinin 1 Receptor AntagonistJournal of Medicinal Chemistry, 2011
- Discovery of a Potent and Efficacious Peptide Derivative for δ/μ Opioid Agonist/Neurokinin 1 Antagonist Activity with a 2′,6′-Dimethyl-l-Tyrosine: In vitro, In vivo, and NMR-Based Structural StudiesJournal of Medicinal Chemistry, 2011
- Spinal or systemic TY005, a peptidic opioid agonist/neurokinin 1 antagonist, attenuates pain with reduced toleranceBritish Journal of Pharmacology, 2010
- Biological and Conformational Evaluation of Bifunctional Compounds for Opioid Receptor Agonists and Neurokinin 1 Receptor Antagonists Possessing Two PenicillaminesJournal of Medicinal Chemistry, 2010
- AutoDock4 and AutoDockTools4: Automated docking with selective receptor flexibilityJournal of Computational Chemistry, 2009
- The NK-1 receptor antagonist aprepitant as a broad spectrum antitumor drugInvestigational New Drugs, 2009
- A Structure–Activity Relationship Study and Combinatorial Synthetic Approach of C-Terminal Modified Bifunctional Peptides That Are δ/μ Opioid Receptor Agonists and Neurokinin 1 Receptor AntagonistsJournal of Medicinal Chemistry, 2008
- Design, Synthesis, and Biological Evaluation of Novel Bifunctional C-Terminal-Modified Peptides for δ/μ Opioid Receptor Agonists and Neurokinin-1 Receptor AntagonistsJournal of Medicinal Chemistry, 2007